Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Fulda

Showing results (91-100 of 287) with videos related to

Pageof 29
Sort By:
Critical Care Medicine|May 27, 2011
Propofol--sweet dreams, but not for everyone?Mario Perl, Florian Gebhard, Simone Fulda
Cancer Letters|March 6, 2016
Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cellsSteve Gerges, Katharina Rohde, Simone Fulda
EMBO Molecular Medicine|June 26, 2012
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implicationsSimone Fulda, Krishnaraj Rajalingam, Ivan Dikic
Cancer Letters|April 29, 2015
Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcomaAngelika Stehle, Manuela Hugle, Simone Fulda
The Journal of Biological Chemistry|August 29, 2012
RIP1 protein-dependent assembly of a cytosolic cell death complex is required for inhibitor of apoptosis (IAP) inhibitor-mediated sensitization to lexatumumab-induced apoptosisFarhan Basit, Robin Humphreys, Simone Fulda
Oncotarget|March 10, 2015
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcomaUlrike Graab, Heidi Hahn, Simone Fulda
Oncotarget|April 18, 2018
Regulation of the antiapoptotic protein cFLIP by the glucocorticoid Dexamethasone in ALL cellsLara Kleinesudeik, Katharina Rohde, Simone Fulda
Drug Discovery Today|January 26, 2010
IAP antagonists: promising candidates for cancer therapyRaimund Mannhold, Simone Fulda, Emanuele Carosati
Frontiers in Oncology|March 1, 2016
Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future ChallengesThomas G P Grünewald, Simone Fulda
Anti-Cancer Drugs|September 27, 2016
Reactive oxygen species contribute toward Smac mimetic/temozolomide-induced cell death in glioblastoma cellsMathieu Seyfrid, Viola Marschall, Simone Fulda
Pageof 29

Showing results (91-100 of 287) with videos related to

Sort By:
Pageof 29
Critical Care Medicine|May 27, 2011
Propofol--sweet dreams, but not for everyone?Mario Perl, Florian Gebhard, Simone Fulda
Cancer Letters|March 6, 2016
Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cellsSteve Gerges, Katharina Rohde, Simone Fulda
EMBO Molecular Medicine|June 26, 2012
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implicationsSimone Fulda, Krishnaraj Rajalingam, Ivan Dikic
Cancer Letters|April 29, 2015
Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcomaAngelika Stehle, Manuela Hugle, Simone Fulda
The Journal of Biological Chemistry|August 29, 2012
RIP1 protein-dependent assembly of a cytosolic cell death complex is required for inhibitor of apoptosis (IAP) inhibitor-mediated sensitization to lexatumumab-induced apoptosisFarhan Basit, Robin Humphreys, Simone Fulda
Oncotarget|March 10, 2015
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcomaUlrike Graab, Heidi Hahn, Simone Fulda
Oncotarget|April 18, 2018
Regulation of the antiapoptotic protein cFLIP by the glucocorticoid Dexamethasone in ALL cellsLara Kleinesudeik, Katharina Rohde, Simone Fulda
Drug Discovery Today|January 26, 2010
IAP antagonists: promising candidates for cancer therapyRaimund Mannhold, Simone Fulda, Emanuele Carosati
Frontiers in Oncology|March 1, 2016
Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future ChallengesThomas G P Grünewald, Simone Fulda
Anti-Cancer Drugs|September 27, 2016
Reactive oxygen species contribute toward Smac mimetic/temozolomide-induced cell death in glioblastoma cellsMathieu Seyfrid, Viola Marschall, Simone Fulda
Pageof 29